Schedule 13G ownership disclosure
ALX Oncology Holdings, Inc.
Common Stock, par value $0.001 per share · CUSIP: 00166B105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 3,296,883.00 · Class: 6.3%
- KEVIN TANG
Shares: 3,296,883.00 · Class: 6.3%
- TANG CAPITAL PARTNERS, LP
Shares: 3,296,883.00 · Class: 6.3%
- TANG CAPITAL PARTNERS III, INC
Shares: 0.00 · Class: 0.0%
- TANG CAPITAL PARTNERS IV, INC
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-002805
- Form type
- SCHEDULE 13G/A
- Filer
- ALX ONCOLOGY HOLDINGS INC
- CIK
- CIK 1810182
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership